RecruitingNCT05967910

The Effect of Chronic Stress on Efficacy of ICIs in Esophageal Cancer Patients (STRESS-ESCA Study)

The Effect of Chronic Stress on Efficacy of Immune Checkpoint Inhibitors in Patients With Newly Diagnosed Esophageal Cancer


Sponsor

Second Xiangya Hospital of Central South University

Enrollment

200 participants

Start Date

May 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Chronic stress refers to a special emotional state caused by unexpected stress for a long time, with an increasing incidence in the population. It can cause the body to release hormones such as cortisol and adrenaline. Tumor patients often experience changes such as psychological and emotional abnormalities, decreased quality of life, and impaired social relationships. Under stimulation, patients often experience negative reactions such as anxiety or depression. Epidemiological studies have shown that stress can affect the prognosis of malignant tumors, but the effect of stress on the efficacy and prognosis of esophageal cancer is still unclear. In animal models, chronic stress leads to an increase in tissue catecholamine levels, increased tumor burden, and increased invasiveness of ovarian cancer cells in mouse models. At the same time, stress can promote tumor neovascularization in mice. However, the mechanism by which chronic stress affects the occurrence and development of esophageal cancer is currently unclear. In addition to neurohumoral factors, chronic stress can cause changes in the gut microbiota, which in turn affects the body's digestion, metabolism, and immune function. It is a key gatekeeper of the immune response to tumors. Therefore, gut microbiota as an intermediate factor may also affect the occurrence and prognosis of various types of esophageal cancer.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study (called STRESS-ESCA) is looking at whether chronic stress affects how well immunotherapy works in people with esophageal cancer. Immunotherapy drugs help your immune system fight cancer, and researchers want to know if being under long-term stress changes how effective these treatments are. **You may be eligible if...** - You have been diagnosed with esophageal cancer confirmed by a biopsy - You are between 18 and 75 years old - You have not yet received any systemic (whole-body) treatment for your cancer - You have at least one measurable tumor that can be tracked during treatment - Your heart, liver, and kidney function are within acceptable ranges **You may NOT be eligible if...** - You have another type of cancer at the same time - You have been taking steroids or immune-suppressing medications long-term - You currently have an acute or chronic mental health condition - You take medications that affect your nervous system's stress response long-term - You have previously participated in another clinical drug trial - You have brain metastases with symptoms Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERchronic psychological stress

Chronic psychological stress includes symptoms of anxiety and depression.


Locations(1)

Department of Oncology, The Second Xiangya Hospital, Central South University

Changsha, Hunan, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05967910


Related Trials